NCT00250809

Brief Summary

CVC Pros and Cons of scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 1994

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 1994

Completed
11.7 years until next milestone

First Submitted

Initial submission to the registry

November 4, 2005

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 8, 2005

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2005

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2006

Completed
Last Updated

January 12, 2024

Status Verified

January 1, 2024

Enrollment Period

11.8 years

First QC Date

November 4, 2005

Last Update Submit

January 10, 2024

Conditions

Other Female GenitalCancer

Outcome Measures

Primary Outcomes (1)

  • Pros and Cons of scheduled Triple-lumen Central Venous Catheter Exchange

    3 years

Interventions

Placement of a central venous catheterPROCEDURE

Placement of a central venous catheter

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Patients who require the placement of a central venous catheter for medical purposes and have an absence of infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of New Mexico

Albuquerque, New Mexico, 87131, United States

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Harriet Smith, MD

    University of New Mexico

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 4, 2005

First Posted

November 8, 2005

Study Start

March 1, 1994

Primary Completion

December 1, 2005

Study Completion

March 1, 2006

Last Updated

January 12, 2024

Record last verified: 2024-01

Locations

US(1)